Bladder Cancer - Results from #300

Long-Term Renal Function in Patients with CKD following Radical Cystectomy and Orthotopic Neobladder. January 21, 2022

The Cancer of the Bladder Risk Assessment (COBRA) score accurately predicts cancer-specific survival after radical cystectomy: external validation and lymphovascular invasion assessment value to improve its performance. January 21, 2022

Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells. January 21, 2022

Targeted Sequencing of Non-schistosomal Squamous Cell Carcinoma of the Urinary Bladder – Expert Commentary January 20, 2022

Culture of Bladder Cancer Organoids as Precision Medicine Tools. January 20, 2022

Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis. January 20, 2022

Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial. January 19, 2022

Bladder cancer in patients with neurogenic bladder disorder: a comparative study of different etiologies. January 19, 2022

Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study. January 19, 2022

Residual CIS after Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle Invasive Bladder Cancer: Implications for Neoadjuvant Trials January 18, 2022

Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer. January 18, 2022

Modified 5-Item Frailty Index Score as Prognostic Marker After Radical Cystectomy in Bladder Cancer. January 18, 2022

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study. January 17, 2022

Treatment disparities in muscle-invasive bladder cancer: Evidence from a large statewide cancer registry. January 17, 2022

Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Hea January 17, 2022

Association of Recommended and Non-Recommended Food Score and Risk of Bladder Cancer: A Case-Control Study. January 14, 2022

Transurethral Resection of Non-Muscle Invasive Bladder Tumors Combined with Fluorescence Diagnosis and Photodynamic Therapy with Chlorin e6-Type Photosensitizers. January 14, 2022

Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups. January 13, 2022

Avelumab in locally advanced or metastatic urothelial carcinoma. January 13, 2022

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. January 13, 2022

Page 16 of 432

email news signup